Table 1.
Factors | No. | 5-year survival (%) | p |
---|---|---|---|
Age, year | |||
≤65 | 83 | 45.3% | 0.662 |
>65 | 35 | 48.8% | |
Sex | |||
Male | 98 | 49.2% | 0.295 |
Female | 20 | 35% | |
Tumor location | |||
Upper | 17 | 29.4% | 0.034 |
Middle | 68 | 52.3% | |
Lower | 33 | 43.7% | |
Surgical type | 0.107 | ||
2-FL | 60 | 52.3% | |
3-FL | 58 | 41.1% | |
Differentiation | |||
Well | 8 | 87.5 | 0.117 |
Moderately | 73 | 40.7 | |
Poorly | 37 | 50.3 | |
T stage | |||
T1+ T2 | 60 | 66.1 | 0.000 |
T3+T4 | 58 | 26.3 | |
TNM stage | |||
I | 22 | 85.2 | 0.000 |
II | 48 | 59.7 | |
III | 37 | 18.1 | |
IV | 11 | 13.6 | |
Beclin-1 | |||
Positive | 68 | 54.5 | 0.007 |
Negative | 50 | 35.1 | |
LC3 | |||
Positive | 57 | 61.3 | 0.021 |
Negative | 61 | 33.0 |